Matrix Capital Management Company, LP

ZNTL

Matrix Capital Management Company, LP serves as 10 percent owner at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$107.86M

Total Sells

1 trades

$39.05M

Net Position

Net Buyer

$68.82M

Companies Traded

AURA, ZNTL

Active Period

Jun 2023 – May 2026

2 total trades

Most Recent

Sell AURA

May 11, 2026 · $39.05M

Matrix Capital Management Company, LP's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

1 · $107.86M

Sells

0 · $0.00

Total Shares Bought

4,760,000

Total Shares Sold

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 20, 2023	Buy	4,760,000	$22.66	$107.86M	13,959,973

Matrix Capital Management Company, LP's Insider Trading at Aura Biosciences, Inc. (AURA)

Buys

0 · $0.00

Sells

1 · $39.05M

Total Shares Bought

Total Shares Sold

6,922,870

AURA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 11, 2026	Sell	6,922,870	$5.64	$39.05M	0

Related Insiders

Conor Kilroy

See Remarks

AURASell · Apr 16, 2026

Mark Plavsic

Chief Technology Officer

AURASell · Feb 17, 2026

los Pinos Elisabet de

See Remarks

AURASell · Feb 17, 2026

Amy Elazzouzi

Senior Vice President, Finance

AURASell · Feb 17, 2026

Janet Jill Hopkins

Chief Medical Officer

AURASell · Feb 17, 2026

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity